Events
Conferences we attend
Upcoming Conferences
Virtual or in person, we participate in many conferences as speakers, exhibitors or attendees.
We regularly attend conferences organised by the American Chemical Society (ACS), the Royal Society of Chemistry, The International Society for the Study of Xenobiotics (ISSX), the Drug Metabolism Discussion Group (DMDG) the Society of Chemical Industry (SCI), the Pharmaceutical and Bioscience Society (PBSS) and The Boston Society.
Let us know if you’d like to connect at any of the meetings we’re attending this year.
Frank will be attending the NEDMDG Fall 2023 meeting being held on 14th September at Sanofi-Aventis in Cambridge, MA.
Frank Scheffler will be exhibiting with our partner KRCC at The 44th Korean Society for Non-Clinical Trial and Research (KSNS) Workshop being held 19-20 October 2023 in South Korea.
Frank Scheffler will be at the 2023 ICCP/JSSX conference being held 25-29 September 2023 in Japan, where BioBridge will be exhibiting and representing Hypha.
Hypha will be exhibiting at the SCI / RSC 22nd Medicinal Chemistry Symposium being held 10-13 September 2023 at Churchill College, Cambridge, UK. Drop by our exhibit and have a chat with Liam.
Julia and Frank will be at the 25th North American ISSX Meeting being held 10-13 September 2023 in Boston, USA. Stop by our booth or visit our poster during the conference.
Frank Scheffler will be exhibiting at the 3rd RSC Anglo-Nordic Medicinal Chemistry Symposium being held in Denmark from 13-16 July 2023.
Julia Shanu-Wilson and Liam Evans will be exhibiting at the 16th European ISSX and DMDG Meeting at the University of Hertfordshire, UK from 11-14 June 2023.
Frank Scheffler will be exhibiting at the Hatfield MedChem Meeting being held in Hatfield, UK on Thursday 27th April 2023.
Stay up to date with the latest news from Hypha Discovery
Sign up for our quarterly newsletters and monthly "Metabolite Tales" blog
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.